GLP1-EGFA heterodimer protein (Leto Laboratories)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameGLP1-EGFA heterodimer protein (Leto Laboratories)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsProprotein convertase subtilisin kexin type 9 inhibitors
TargetsGlucagon-like peptide 1 receptorProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHyperlipidemiasHyperglycemiaDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLeto Laboratories Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLeto Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHyperglycemiaDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A